|
G |
App |
amyloid beta precursor protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:31939705 |
|
NCBI chrNW_004936640:1,549,977...1,787,436
|
|
|
G |
App |
amyloid beta precursor protein |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936640:1,549,977...1,787,436
|
|
|
G |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
|
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936469:8,653,031...9,209,840
|
|
G |
Braf |
B-Raf proto-oncogene, serine/threonine kinase |
|
ISO |
ClinVar Annotator: match by term: Arteriovenous malformations of the brain ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:12068308 PMID:12198537 PMID:12447372 PMID:12460918 PMID:12460919 PMID:12619120 PMID:12644542 PMID:12670889 PMID:12794760 PMID:12960123 PMID:14513361 PMID:14602780 PMID:14679157 PMID:15001635 PMID:15035987 PMID:15126572 PMID:15181070 PMID:15342696 PMID:15356022 PMID:15386408 PMID:15687339 PMID:15998781 PMID:16015629 PMID:16174717 PMID:16187918 PMID:16772349 PMID:17374713 PMID:17488796 PMID:17785355 PMID:18398503 PMID:19001320 PMID:19010912 PMID:19018267 PMID:19238210 PMID:19404918 PMID:19537845 PMID:19561230 PMID:20008640 PMID:20350999 PMID:20413299 PMID:20619739 PMID:20630094 PMID:20818844 PMID:20823850 PMID:20857202 PMID:21107320 PMID:21107323 PMID:21129611 PMID:21156289 PMID:21163703 PMID:21426297 PMID:21483012 PMID:21502544 PMID:21639808 PMID:21641636 PMID:21683865 PMID:21975775 PMID:22038996 PMID:22048237 PMID:22113612 PMID:22180495 PMID:22281684 PMID:22351686 PMID:22356324 PMID:22389471 PMID:22448344 PMID:22536370 PMID:22586120 PMID:22608338 PMID:22649091 PMID:22663011 PMID:22735384 PMID:22743296 PMID:22773810 PMID:22805292 PMID:22972589 PMID:22997239 PMID:23020132 PMID:23031422 PMID:23251002 PMID:23302800 PMID:23325582 PMID:23470635 PMID:23524406 PMID:23549875 PMID:23614898 PMID:23685455 PMID:23812671 PMID:23833300 PMID:23845441 PMID:23918947 PMID:24107445 PMID:24112392 PMID:24163374 PMID:24388723 PMID:24508103 PMID:24512911 PMID:24576830 PMID:24583796 PMID:24586605 PMID:24594804 PMID:24670642 PMID:24717435 PMID:25024077 PMID:25037139 PMID:25079330 PMID:25157968 PMID:25265492 PMID:25265494 PMID:25370471 PMID:25399551 PMID:25950823 PMID:25989278 PMID:26619011 PMID:26678033 PMID:27404270 PMID:27480103 PMID:28854169 PMID:28891408 PMID:29925953 PMID:31779674 PMID:31891627 |
|
NCBI chrNW_004936592:4,728,371...4,833,830
|
|
G |
Cacna1h |
calcium voltage-gated channel subunit alpha1 H |
|
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936694:2,702,224...2,724,574
|
|
G |
Ccnh |
cyclin H |
|
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:30311386 |
|
NCBI chrNW_004936469:5,933,163...5,952,190
|
|
G |
Cdh2 |
cadherin 2 |
|
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936550:6,885,484...7,067,001
|
|
G |
Egfr |
epidermal growth factor receptor |
|
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936678:365,005...560,546
|
|
G |
Eng |
endoglin |
disease_progression |
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation DNA:polymorphism: : 207G>A(human) |
RGD ClinVar |
PMID:16179574 PMID:24520391 PMID:24876084 PMID:25741868 |
RGD:11041171 RGD:11041564 RGD:1580962 |
NCBI chrNW_004936487:15,467,165...15,499,180
|
|
G |
Flt1 |
fms related receptor tyrosine kinase 1 |
|
ISO |
protein:increased expression:endothelial cell: |
RGD |
PMID:11220380 |
RGD:8551824 |
NCBI chrNW_004936472:23,442,946...23,617,523
|
|
G |
Gli2 |
GLI family zinc finger 2 |
|
ISO |
ClinVar Annotator: match by term: Arteriovenous malformations of the brain |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936469:49,616,552...49,788,760
|
|
G |
Il17rd |
interleukin 17 receptor D |
|
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:25636053 PMID:25741868 |
|
NCBI chrNW_004936473:7,447,292...7,507,819
|
|
G |
Kdr |
kinase insert domain receptor |
|
ISO |
protein:increased expression:endothelial cell: |
RGD |
PMID:11220380 |
RGD:8551824 |
NCBI chrNW_004936482:17,537,697...17,581,320
|
|
G |
Kras |
KRAS proto-oncogene, GTPase |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936548:2,078,568...2,113,877
|
|
G |
Lemd3 |
LEM domain containing 3 |
|
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936545:3,385,821...3,453,861
|
|
G |
LOC101976737 |
zinc finger FYVE domain-containing protein 16 |
|
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936549:8,082,464...8,110,116
|
|
G |
Map4k4 |
mitogen-activated protein kinase kinase kinase kinase 4 |
|
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936713:515,388...616,024
|
|
G |
Notch4 |
notch receptor 4 |
|
ISO |
|
RGD |
PMID:19546852 |
RGD:6480671 |
NCBI chrNW_004936727:1,386,842...1,409,823
|
|
G |
Pdcd10 |
programmed cell death 10 |
|
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936593:4,650,624...4,693,387
|
|
G |
Pitpnm3 |
PITPNM family member 3 |
|
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936677:1,451,974...1,528,864
|
|
G |
Prex2 |
phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2 |
|
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936496:6,005,410...6,284,332
|
|
G |
Rasa1 |
RAS p21 protein activator 1 |
|
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:30311386 |
|
NCBI chrNW_004936469:5,839,560...5,933,049
|
|
G |
Sars1 |
seryl-tRNA synthetase 1 |
|
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936704:747,109...766,981
|
|
G |
Scube2 |
signal peptide, CUB domain and EGF like domain containing 2 |
|
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936528:8,981,079...9,060,033
|
|
G |
Syn3 |
synapsin III |
|
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936492:6,836,441...7,253,867
|
|
G |
Timp3 |
TIMP metallopeptidase inhibitor 3 |
|
ISO |
ClinVar Annotator: match by term: Cerebral arteriovenous malformation |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936492:6,996,627...7,046,137
|
|
G |
Vegfa |
vascular endothelial growth factor A |
|
ISO |
|
RGD |
PMID:16388189 |
RGD:1580567 |
NCBI chrNW_004936476:16,245,134...16,261,180
|
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
|
|
NCBI chrNW_004936486:11,271,130...11,317,271
|
|
G |
Notch3 |
notch receptor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism ClinVar Annotator: match by term: Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy |
CTD ClinVar |
PMID:15229130 PMID:25741868 PMID:26467025 |
|
NCBI chrNW_004936596:5,265,984...5,301,430
|
|
|
G |
Notch3 |
notch receptor 3 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936596:5,265,984...5,301,430
|
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936486:11,271,130...11,317,271
|
|
|
G |
Aoc3 |
amine oxidase copper containing 3 |
|
ISO |
associated with Alzheimer Disease;protein:increased expression:brain |
RGD |
PMID:17393059 |
RGD:2313919 |
NCBI chrNW_004936490:17,549,836...17,564,867
|
|
G |
Apoa1 |
apolipoprotein A1 |
|
ISO |
|
RGD |
PMID:20739292 |
RGD:5508213 |
NCBI chrNW_004936542:2,111,055...2,112,626
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:11061249 |
|
NCBI chrNW_004936706:1,512,438...1,516,805
|
|
G |
App |
amyloid beta precursor protein |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21520056 |
|
NCBI chrNW_004936640:1,549,977...1,787,436
|
|
G |
Aqp4 |
aquaporin 4 |
|
ISO |
|
RGD |
PMID:21107133 |
RGD:5148012 |
NCBI chrNW_004936550:5,931,201...5,943,999
|
|
G |
LOC101964209 |
C-C chemokine receptor type 1 |
|
ISO |
|
RGD |
PMID:14595653 |
RGD:5688166 |
NCBI chrNW_004936596:177,774...183,186
|
|
G |
Mme |
membrane metalloendopeptidase |
severity |
ISO |
associated with Alzheimer Disease;protein:decreased expression:frontal lobe cortex (human) |
RGD |
PMID:17021406 PMID:21382117 |
RGD:13801026 RGD:1600811 |
NCBI chrNW_004936519:2,513,896...2,595,896
|
|
G |
Olr1 |
oxidized low density lipoprotein receptor 1 |
|
ISO |
|
RGD |
PMID:16328515 |
RGD:1580993 |
NCBI chrNW_004936902:405,536...416,393
|
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936486:11,271,130...11,317,271
|
|
|
G |
App |
amyloid beta precursor protein |
|
ISO |
ClinVar Annotator: match by term: Hereditary cerebral hemorrhage with amyloidosis |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936640:1,549,977...1,787,436
|
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
|
ISO |
associated with Diabetes Mellitus, Experimental |
RGD |
PMID:23844137 |
RGD:8547935 |
NCBI chrNW_004936727:1,418,342...1,422,005
|
|
G |
Aoc3 |
amine oxidase copper containing 3 |
|
ISO |
protein:decreased expression:cerebral artery |
RGD |
PMID:18312104 |
RGD:2313912 |
NCBI chrNW_004936490:17,549,836...17,564,867
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:25316629 |
RGD:11522723 |
NCBI chrNW_004936497:2,209,136...2,373,580
|
|
G |
Col1a2 |
collagen type I alpha 2 chain |
|
ISO |
|
RGD |
PMID:14739420 |
RGD:1581199 |
NCBI chrNW_004936585:5,650,322...5,686,393
|
|
G |
Col22a1 |
collagen type XXII alpha 1 chain |
susceptibility |
ISO |
DNA:SNPs:cds:multiple(human) |
RGD |
PMID:30541770 |
RGD:13831344 |
NCBI chrNW_004936470:11,762,312...11,994,041
|
|
G |
Ctsk |
cathepsin K |
|
ISO |
protein:increased expression:brain, artery mRNA:increased expression:brain, artery |
RGD |
PMID:18635848 |
RGD:2306495 |
NCBI chrNW_004936580:1,022,762...1,038,020
|
|
G |
Ctss |
cathepsin S |
|
ISO |
mRNA:increased expression:brain, artery protein:increased expression:brain, artery |
RGD |
PMID:18635848 |
RGD:2306495 |
NCBI chrNW_004936580:963,176...991,732
|
|
G |
Eng |
endoglin |
|
ISO |
|
RGD |
PMID:10223461 |
RGD:1580964 |
NCBI chrNW_004936487:15,467,165...15,499,180
|
|
G |
Fbn2 |
fibrillin 2 |
|
ISO |
ClinVar Annotator: match by term: Brain Aneurysm |
ClinVar |
PMID:16835936 PMID:19006240 PMID:25525159 PMID:25741868 PMID:26038974 PMID:28492532 |
|
NCBI chrNW_004936504:1,535,629...1,757,386
|
|
G |
Mmp12 |
matrix metallopeptidase 12 |
no_association |
ISO |
|
RGD |
PMID:11546917 |
RGD:1582365 |
NCBI chrNW_004936551:5,107,567...5,117,843
|
|
G |
Mmp14 |
matrix metallopeptidase 14 |
|
ISO |
|
RGD |
PMID:9724118 |
RGD:1582590 |
NCBI chrNW_004936722:1,447,189...1,457,632
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
susceptibility |
ISO |
mRNA:increased expression:blood vessel |
RGD |
PMID:9724118 PMID:16961137 PMID:17569872 |
RGD:1582590 RGD:1582646 RGD:2290352 |
NCBI chrNW_004936475:7,801,356...7,825,831
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
treatment susceptibility |
ISO |
associated with Diabetes Mellitus, Experimental mRNA:increased expression:blood vessel mRNA, protein:increased expression:artery |
RGD |
PMID:9310982 PMID:16961137 PMID:17122420 PMID:17569872 PMID:21937941 PMID:23844137 |
RGD:13204853 RGD:13204858 RGD:1582646 RGD:1642055 RGD:2290352 RGD:8547935 |
NCBI chrNW_004936514:7,038,240...7,045,873
|
|
G |
Ncf1 |
neutrophil cytosolic factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19381132 |
|
NCBI chrNW_004936543:3,617,369...3,630,990
|
|
G |
Nos1 |
nitric oxide synthase 1 |
|
ISO |
|
RGD |
PMID:21321533 |
RGD:5131897 |
NCBI chrNW_004936558:5,162,471...5,302,488
|
|
G |
Nos3 |
nitric oxide synthase 3 |
|
ISO |
|
RGD |
PMID:21321533 |
RGD:5131897 |
NCBI chrNW_004936527:6,427,147...6,445,770
|
|
G |
Pkd1 |
polycystin 1, transient receptor potential channel interacting |
susceptibility |
ISO |
DNA:mutations:multiple (human) ClinVar Annotator: match by term: Brain aneurysm |
RGD ClinVar |
PMID:12842373 PMID:25741868 |
RGD:1580867 |
NCBI chrNW_004936694:1,923,383...1,958,160
|
|
G |
Pkd2 |
polycystin 2, transient receptor potential cation channel |
susceptibility |
ISO |
DNA:mutations:multiple (human) |
RGD |
PMID:12842373 |
RGD:1580867 |
NCBI chrNW_004936905:76,781...128,995
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
|
RGD |
PMID:21786025 |
RGD:6483795 |
NCBI chrNW_004936521:5,238,128...5,243,829
|
|
G |
Smad3 |
SMAD family member 3 |
|
ISO |
ClinVar Annotator: match by term: Intracranial aneurysm |
ClinVar |
PMID:25326637 PMID:25741868 PMID:30311386 |
|
NCBI chrNW_004936471:27,080,662...27,185,861
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
ISO |
|
RGD |
PMID:17569872 |
RGD:2290352 |
NCBI chrNW_004936502:13,345,936...13,350,170
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
ISO |
mRNA:increased expression:blood vessel |
RGD |
PMID:17569872 |
RGD:2290352 |
NCBI chrNW_004936594:3,232,433...3,244,241
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
ISO |
|
RGD |
PMID:24628611 |
RGD:10450592 |
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Vcan |
versican |
|
ISO |
DNA:SNP: :rs173686 (human) |
RGD |
PMID:16917090 |
RGD:1598495 |
NCBI chrNW_004936469:2,585,142...2,688,029
|
|
|
G |
Thsd1 |
thrombospondin type 1 domain containing 1 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936565:4,925,400...4,952,210
|
|
|
G |
Itm2b |
integral membrane protein 2B |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936565:1,535,570...1,557,667
|
|
|
G |
Itm2b |
integral membrane protein 2B |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936565:1,535,570...1,557,667
|
|
|
G |
Abcc8 |
ATP binding cassette subfamily C member 8 |
treatment |
ISO |
|
RGD |
PMID:23149556 PMID:24602692 |
RGD:12790979 RGD:12791996 |
NCBI chrNW_004936528:1,608,782...1,682,873
|
|
G |
Ace2 |
angiotensin I converting enzyme 2 |
|
ISO |
mRNA, protein:increased expression:brain |
RGD |
PMID:24090950 |
RGD:9685436 |
NCBI chrNW_004936470:4,964,526...5,011,808
|
|
G |
Adora1 |
adenosine A1 receptor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23437309 |
|
NCBI chrNW_004936567:1,430,128...1,508,626
|
|
G |
Ager |
advanced glycosylation end-product specific receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism associated with Diabetes Mellitus, Experimental |
CTD RGD |
PMID:24211797 PMID:25446913 |
RGD:8696008 |
NCBI chrNW_004936727:1,418,342...1,422,005
|
|
G |
Agt |
angiotensinogen |
|
ISO |
protein:increased expression:brain, serum |
RGD |
PMID:24090950 |
RGD:9685436 |
NCBI chrNW_004936484:19,713,299...19,721,144
|
|
G |
Aifm1 |
apoptosis inducing factor mitochondria associated 1 |
|
ISO |
protein:altered localization: : |
RGD |
PMID:15181376 |
RGD:10047403 |
NCBI chrNW_004936479:1,441,508...1,477,133
|
|
G |
Ak1 |
adenylate kinase 1 |
|
ISO |
protein:decreased expression:cerebral cortex (rat) |
RGD |
PMID:16468349 |
RGD:5508760 |
NCBI chrNW_004936487:15,507,663...15,517,401
|
|
G |
Alox5 |
arachidonate 5-lipoxygenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19309543 |
|
NCBI chrNW_004936554:7,807,914...7,848,691
|
|
G |
Ap2b1 |
adaptor related protein complex 2 subunit beta 1 |
|
ISO |
protein:increased degradation:brain |
RGD |
PMID:19240038 |
RGD:13461853 |
NCBI chrNW_004936490:5,156...127,666
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
treatment |
ISO |
|
RGD |
PMID:24012531 |
RGD:13703113 |
NCBI chrNW_004936492:14,818,561...14,902,231
|
|
G |
Apoe |
apolipoprotein E |
|
ISO |
|
RGD |
PMID:19623195 |
RGD:6903926 |
NCBI chrNW_004936706:1,512,438...1,516,805
|
|
G |
App |
amyloid beta precursor protein |
treatment |
ISO |
|
RGD |
PMID:28963051 |
RGD:13782054 |
NCBI chrNW_004936640:1,549,977...1,787,436
|
|
G |
Aqp4 |
aquaporin 4 |
treatment |
ISO |
|
RGD |
PMID:20815926 |
RGD:8695955 |
NCBI chrNW_004936550:5,931,201...5,943,999
|
|
G |
Arc |
activity regulated cytoskeleton associated protein |
|
ISO |
|
RGD |
PMID:22645329 |
RGD:10395314 |
NCBI chrNW_004936470:9,185,145...9,188,260
|
|
G |
Atf3 |
activating transcription factor 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12374626 |
|
NCBI chrNW_004936557:909,302...922,619
|
|
G |
Bad |
BCL2 associated agonist of cell death |
treatment |
ISO |
|
RGD |
PMID:21891976 PMID:22200499 |
RGD:10053665 RGD:10053704 |
NCBI chrNW_004936599:4,924,349...4,933,683
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:23143152 |
RGD:10054501 |
NCBI chrNW_004936664:2,968,103...2,973,652
|
|
G |
Bcan |
brevican |
|
ISO |
|
RGD |
PMID:15869933 |
RGD:9590118 |
NCBI chrNW_004936580:5,816,196...5,828,531
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:23143152 |
RGD:10054501 |
NCBI chrNW_004936497:2,209,136...2,373,580
|
|
G |
Bdnf |
brain derived neurotrophic factor |
treatment |
ISO |
|
RGD |
PMID:20417695 |
RGD:4891138 |
NCBI chrNW_004936540:5,530,081...5,582,765
|
|
G |
Becn1 |
beclin 1 |
treatment |
ISO |
|
RGD |
PMID:22108007 |
RGD:11561900 |
NCBI chrNW_004936490:17,518,100...17,531,126
|
|
G |
Bnip3 |
BCL2 interacting protein 3 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:17379825 |
RGD:9685412 |
NCBI chrNW_004936486:18,449,371...18,460,435
|
|
G |
Bnip3l |
BCL2 interacting protein 3 like |
|
ISO |
|
RGD |
PMID:15902200 PMID:21029239 |
RGD:2314138 RGD:9068917 |
NCBI chrNW_004936757:499,485...523,494
|
|
G |
C3 |
complement C3 |
|
ISO |
CTD Direct Evidence: marker/mechanism protein:increased expression:plasma |
CTD RGD |
PMID:22103620 PMID:23199288 |
RGD:7175514 |
NCBI chrNW_004936588:3,985,732...4,023,221
|
|
G |
Camk2a |
calcium/calmodulin dependent protein kinase II alpha |
|
ISO |
|
RGD |
PMID:14688616 |
RGD:1358416 |
NCBI chrNW_004936504:4,636,863...4,700,887
|
|
G |
Casp3 |
caspase 3 |
treatment |
ISO |
|
RGD |
PMID:21891976 PMID:23143152 PMID:26868427 |
RGD:10053704 RGD:10054501 RGD:13782346 |
NCBI chrNW_004936554:4,571,072...4,593,765
|
|
G |
Casp6 |
caspase 6 |
|
ISO |
|
RGD |
PMID:26868427 |
RGD:13782346 |
NCBI chrNW_004936563:912,502...920,025
|
|
G |
Casp9 |
caspase 9 |
treatment |
ISO |
|
RGD |
PMID:26868427 |
RGD:13782346 |
NCBI chrNW_004936474:3,178,097...3,196,130
|
|
G |
Cd36 |
CD36 molecule |
treatment |
ISO |
|
RGD |
PMID:25216018 |
RGD:11041113 |
NCBI chrNW_004936810:791,823...838,303
|
|
G |
Cd86 |
CD86 molecule |
|
ISO |
protein:increased expression:brain subventricular zone, microglial cell (rat) |
RGD |
PMID:19053043 |
RGD:2313025 |
NCBI chrNW_004936536:8,414,491...8,481,712
|
|
G |
Cdk5 |
cyclin dependent kinase 5 |
|
ISO |
|
RGD |
PMID:24920629 |
RGD:13782375 |
NCBI chrNW_004936527:6,478,934...6,483,848
|
|
G |
Cldn5 |
claudin 5 |
treatment |
ISO |
|
RGD |
PMID:24842554 |
RGD:13204729 |
NCBI chrNW_004936619:3,455,508...3,457,053
|
|
G |
Crh |
corticotropin releasing hormone |
|
ISO |
protein:decreased expression:median eminence of hypothalamus (rat) |
RGD |
PMID:21741032 |
RGD:5490538 |
NCBI chrNW_004936496:7,759,656...7,761,555
|
|
G |
Crp |
C-reactive protein |
|
ISO |
|
RGD |
PMID:15545914 |
RGD:9585995 |
NCBI chrNW_004936740:885,855...888,854
|
|
G |
Crtc1 |
CREB regulated transcription coactivator 1 |
treatment |
ISO |
|
RGD |
PMID:20417695 |
RGD:4891138 |
NCBI chrNW_004936596:2,551,621...2,625,327
|
|
G |
Csf3 |
colony stimulating factor 3 |
treatment |
ISO |
mRNA, protein:increased expression:brain: |
RGD |
PMID:15530654 PMID:19298757 |
RGD:11039420 RGD:11039425 |
NCBI chrNW_004936490:15,142,526...15,146,375
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
|
ISO |
|
RGD |
PMID:10825390 |
RGD:632989 |
NCBI chrNW_004936676:60,869...63,028
|
|
G |
Cxcr3 |
C-X-C motif chemokine receptor 3 |
|
ISO |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:10825390 |
RGD:632989 |
NCBI chrNW_004936762:66,636...69,694
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
|
ISO |
|
RGD |
PMID:11726790 |
RGD:9588643 |
NCBI chrNW_004936659:520,181...565,496
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
|
ISO |
|
RGD |
PMID:23516428 |
RGD:9589049 |
NCBI chrNW_004936493:6,963,406...7,013,256
|
|
G |
Dynll1 |
dynein light chain LC8-type 1 |
|
ISO |
|
RGD |
PMID:9522364 |
RGD:13208524 |
NCBI chrNW_004936668:451,846...484,841
|
|
G |
Edn1 |
endothelin 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:17197033 |
|
NCBI chrNW_004936534:885,489...892,292
|
|
G |
Egr1 |
early growth response 1 |
|
ISO |
|
RGD |
PMID:22645329 |
RGD:10395314 |
NCBI chrNW_004936531:7,625,956...7,629,041
|
|
G |
Egr2 |
early growth response 2 |
|
ISO |
|
RGD |
PMID:22645329 |
RGD:10395314 |
NCBI chrNW_004936753:1,958,250...1,962,640
|
|
G |
Egr4 |
early growth response 4 |
|
ISO |
|
RGD |
PMID:22645329 |
RGD:10395314 |
NCBI chrNW_004936491:17,068,797...17,071,608
|
|
G |
Eif2s1 |
eukaryotic translation initiation factor 2 subunit alpha |
treatment |
ISO |
|
RGD |
PMID:19763736 PMID:23669639 |
RGD:10395346 RGD:10755569 |
NCBI chrNW_004936495:10,746,687...10,769,304
|
|
G |
Eng |
endoglin |
|
ISO |
|
RGD |
PMID:24876084 |
RGD:11041171 |
NCBI chrNW_004936487:15,467,165...15,499,180
|
|
G |
Epcam |
epithelial cell adhesion molecule |
|
ISO |
|
RGD |
PMID:15950761 |
RGD:11038820 |
NCBI chrNW_004936508:5,019,513...5,032,610
|
|
G |
Epn1 |
epsin 1 |
|
ISO |
protein:increased degradation:brain |
RGD |
PMID:19240038 |
RGD:13461853 |
NCBI chrNW_004936981:194,176...213,021
|
|
G |
Epo |
erythropoietin |
treatment |
ISO |
|
RGD |
PMID:20547143 PMID:20833153 |
RGD:10400898 RGD:10401066 |
NCBI chrNW_004936543:742,722...745,332
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
|
ISO |
|
RGD |
PMID:9974119 |
RGD:10401103 |
NCBI chrNW_004936728:706,499...843,447
|
|
G |
F11 |
coagulation factor XI |
|
ISO |
|
RGD |
PMID:16533887 |
RGD:11041786 |
NCBI chrNW_004936554:3,205,539...3,223,228
|
|
G |
F12 |
coagulation factor XII |
treatment |
ISO |
|
RGD |
PMID:16533887 |
RGD:11041786 |
NCBI chrNW_004936597:1,687,511...1,694,782
|
|
G |
F2 |
coagulation factor II, thrombin |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:29651748 |
|
NCBI chrNW_004936562:2,371,725...2,388,617
|
|
G |
Fadd |
Fas associated via death domain |
treatment |
ISO |
|
RGD |
PMID:18950622 PMID:23378241 |
RGD:11341807 RGD:11344885 |
NCBI chrNW_004936599:633,501...639,412
|
|
G |
Fgf21 |
fibroblast growth factor 21 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25257527 |
|
NCBI chrNW_004936664:2,826,823...2,828,330
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12374626 |
|
NCBI chrNW_004936488:4,384,710...4,388,118
|
|
G |
Gabra6 |
gamma-aminobutyric acid type A receptor subunit alpha6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25257527 |
|
NCBI chrNW_004936515:1,982,415...1,997,740
|
|
G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
ISO |
|
RGD |
PMID:25882840 |
RGD:13792686 |
NCBI chrNW_004936709:1,243,149...1,247,782
|
|
G |
Ghrl |
ghrelin and obestatin prepropeptide |
treatment |
ISO |
|
RGD |
PMID:19352052 |
RGD:9850083 |
NCBI chrNW_004936602:3,037,862...3,044,863
|
|
G |
Ghsr |
growth hormone secretagogue receptor |
|
ISO |
|
RGD |
PMID:19352052 |
RGD:9850083 |
NCBI chrNW_004936593:268,736...273,623
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
treatment |
ISO |
|
RGD |
PMID:26674869 |
RGD:11068571 |
NCBI chrNW_004936669:814,330...838,881
|
|
G |
Grn |
granulin precursor |
treatment |
ISO |
|
RGD |
PMID:23972823 |
RGD:10401661 |
NCBI chrNW_004936541:793,548...800,271
|
|
G |
Grpel1 |
GrpE like 1, mitochondrial |
|
ISO |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:12505684 |
RGD:632868 |
NCBI chrNW_004936477:18,883,556...18,891,108
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
treatment |
ISO |
|
RGD |
PMID:28440874 |
RGD:13792734 |
NCBI chrNW_004936536:6,730,070...6,893,818
|
|
G |
Hamp |
hepcidin antimicrobial peptide |
|
ISO |
mRNA, protein:increased expression:cerebral cortex, hippocampus, corpus striatum |
RGD |
PMID:21957487 |
RGD:11041635 |
NCBI chrNW_004936570:1,009,344...1,010,654
|
|
G |
Has2 |
hyaluronan synthase 2 |
|
ISO |
mRNA:increased expression:brain |
RGD |
PMID:11283406 |
RGD:9588631 |
NCBI chrNW_004936470:25,418,069...25,443,332
|
|
G |
Hdac4 |
histone deacetylase 4 |
treatment |
ISO |
mRNA,protein:decreased expression:brain: |
RGD |
PMID:23480850 |
RGD:9681449 |
NCBI chrNW_004936745:1,730,743...1,942,071
|
|
G |
Hdac5 |
histone deacetylase 5 |
treatment |
ISO |
mRNA,protein:decreased expression:brain: |
RGD |
PMID:23480850 |
RGD:9681449 |
NCBI chrNW_004936541:561,721...598,915
|
|
G |
Hdac9 |
histone deacetylase 9 |
|
ISO |
mRNA:increased expression:brain: |
RGD |
PMID:23480850 |
RGD:9681449 |
NCBI chrNW_004936546:4,398,003...5,247,649
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
treatment |
ISO |
|
RGD |
PMID:21029239 |
RGD:9068917 |
NCBI chrNW_004936495:5,770,988...5,816,157
|
|
G |
Hmgb1 |
high mobility group box 1 |
treatment |
ISO |
|
RGD |
PMID:23480850 |
RGD:9681449 |
NCBI chrNW_004936472:25,236,728...25,246,585
|
|
G |
Hmox1 |
heme oxygenase 1 |
treatment |
ISO |
|
RGD |
PMID:20888632 PMID:23870531 PMID:24252362 |
RGD:10755587 RGD:10755588 RGD:10755755 |
NCBI chrNW_004936492:5,042,353...5,049,216
|
|
G |
Hspa4 |
heat shock protein family A (Hsp70) member 4 |
|
ISO |
rat gene in mouse model |
RGD |
PMID:17473852 PMID:21709150 |
RGD:5688754 RGD:6218961 |
NCBI chrNW_004936647:2,087,650...2,133,343
|
|
G |
Hspd1 |
heat shock protein family D (Hsp60) member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12374626 |
|
NCBI chrNW_004936506:1,678,069...1,687,632
|
|
G |
Htra2 |
HtrA serine peptidase 2 |
|
ISO |
protein:increased expression:brain, cytosol (mouse) protein:increased expression:brain, cytosol (rat) |
RGD |
PMID:15306124 PMID:16978742 |
RGD:2314385 RGD:5688372 |
NCBI chrNW_004936556:741,718...746,016
|
|
G |
Hvcn1 |
hydrogen voltage gated channel 1 |
|
ISO |
|
RGD |
PMID:31250553 |
RGD:14985213 |
NCBI chrNW_004936558:3,581,409...3,609,714
|
|
G |
Icam1 |
intercellular adhesion molecule 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12374626 |
|
NCBI chrNW_004936659:616,570...627,172
|
|
G |
Igf1 |
insulin like growth factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25257527 |
|
NCBI chrNW_004936492:11,709,623...11,784,028
|
|
G |
Ikbkb |
inhibitor of nuclear factor kappa B kinase subunit beta |
treatment |
ISO |
|
RGD |
PMID:16286924 |
RGD:10045955 |
NCBI chrNW_004936785:358,128...406,751
|
|
G |
Il11 |
interleukin 11 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25257527 |
|
NCBI chrNW_004936886:617,531...620,661
|
|
G |
Il13 |
interleukin 13 |
|
ISO |
protein:increased expression:cerebral cortex |
RGD |
PMID:23028794 |
RGD:7204480 |
NCBI chrNW_004936647:2,529,933...2,532,503
|
|
G |
Il1b |
interleukin 1 beta |
treatment |
ISO |
protein:increased expression:cerebral cortex (rat) CTD Direct Evidence: marker/mechanism |
RGD CTD |
PMID:23028794 PMID:24916922 PMID:25257527 PMID:29498696 |
RGD:10450594 RGD:13792833 RGD:7204480 |
NCBI chrNW_004936783:1,251,678...1,256,807
|
|
G |
Il1rn |
interleukin 1 receptor antagonist |
treatment |
ISO |
human gene in a rat model |
RGD |
PMID:7790404 |
RGD:8551708 |
NCBI chrNW_004936783:1,447,158...1,466,331
|
|
G |
Il22 |
interleukin 22 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25257527 |
|
NCBI chrNW_004936545:6,227,118...6,231,745
|
|
G |
Il4 |
interleukin 4 |
|
ISO |
protein:increased expression:cerebral cortex |
RGD |
PMID:23028794 |
RGD:7204480 |
NCBI chrNW_004936647:2,510,457...2,518,576
|
|
G |
Il5 |
interleukin 5 |
|
ISO |
|
RGD |
PMID:23028794 |
RGD:7204480 |
NCBI chrNW_004936647:2,647,982...2,651,477
|
|
G |
Il6r |
interleukin 6 receptor |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chrNW_004936580:4,055,438...4,081,876
|
|
G |
Il6st |
interleukin 6 signal transducer |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chrNW_004936480:11,867,573...11,913,563
|
|
G |
Ina |
internexin neuronal intermediate filament protein alpha |
|
ISO |
|
RGD |
PMID:29967576 |
RGD:27226878 |
NCBI chrNW_004936600:2,747,649...2,760,517
|
|
G |
Irf4 |
interferon regulatory factor 4 |
|
ISO |
|
RGD |
PMID:25652434 |
RGD:11530061 |
NCBI chrNW_004936633:1,565,293...1,580,859
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12374626 |
|
NCBI chrNW_004936659:1,890,786...1,892,619
|
|
G |
LOC101968921 |
angiotensin-converting enzyme |
treatment |
ISO |
|
RGD |
PMID:24471927 |
RGD:11039026 |
NCBI chrNW_004936541:4,157,847...4,178,156
|
|
G |
LOC101973029 |
cytochrome P450 2E1 |
|
ISO |
|
RGD |
PMID:23002367 |
RGD:14700877 |
NCBI chrNW_004936486:19,691,822...19,702,684
|
|
G |
LOC101976500 |
haptoglobin |
|
ISO |
|
RGD |
PMID:22103620 |
RGD:7175514 |
NCBI chrNW_004936475:21,841,054...21,845,821
|
|
G |
Mag |
myelin associated glycoprotein |
treatment |
ISO |
|
RGD |
PMID:15678116 |
RGD:9685232 |
NCBI chrNW_004936570:989,743...1,004,820
|
|
G |
Mapk1 |
mitogen-activated protein kinase 1 |
treatment |
ISO |
|
RGD |
PMID:27152455 |
RGD:13800881 |
NCBI chrNW_004936619:1,889,841...1,932,646
|
|
G |
Mapk3 |
mitogen-activated protein kinase 3 |
treatment |
ISO |
|
RGD |
PMID:27152455 |
RGD:13800881 |
NCBI chrNW_004936501:12,342,670...12,390,650
|
|
G |
Mapt |
microtubule associated protein tau |
treatment |
ISO |
|
RGD |
PMID:25903928 PMID:28886009 |
RGD:13800886 RGD:13800913 |
NCBI chrNW_004936541:2,381,411...2,479,984
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
treatment |
ISO |
CTD Direct Evidence: marker/mechanism |
CTD RGD |
PMID:19309543 PMID:24842554 |
RGD:13204729 |
NCBI chrNW_004936514:7,038,240...7,045,873
|
|
G |
Mt3 |
metallothionein 3 |
|
ISO |
protein:decreased expression:brain |
RGD |
PMID:8869568 |
RGD:9685807 |
NCBI chrNW_004936475:8,864,512...8,866,516
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
treatment |
ISO |
|
RGD |
PMID:21185267 PMID:23777415 PMID:24583056 |
RGD:10040971 RGD:10040974 RGD:10041016 |
NCBI chrNW_004936474:158,376...282,310
|
|
G |
Nae1 |
NEDD8 activating enzyme E1 subunit 1 |
|
ISO |
|
RGD |
PMID:21386696 |
RGD:13801046 |
NCBI chrNW_004936475:17,083,175...17,105,098
|
|
G |
Nampt |
nicotinamide phosphoribosyltransferase |
treatment |
ISO |
|
RGD |
PMID:28495827 |
RGD:13781880 |
NCBI chrNW_004936479:17,682,070...17,716,713
|
|
G |
Nefh |
neurofilament heavy |
|
ISO |
|
RGD |
PMID:29967576 |
RGD:27226878 |
NCBI chrNW_004936657:3,443,406...3,453,096
|
|
G |
Nefl |
neurofilament light |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:29967576 |
RGD:27226878 |
NCBI chrNW_004936757:1,642,122...1,646,499
|
|
G |
Nefm |
neurofilament medium |
|
ISO |
protein:altered expression:brain |
RGD |
PMID:29967576 |
RGD:27226878 |
NCBI chrNW_004936757:1,662,905...1,668,707
|
|
G |
Nfe2l2 |
nuclear factor, erythroid 2 like 2 |
treatment |
ISO |
|
RGD |
PMID:23880501 PMID:24466583 |
RGD:10412696 RGD:10412714 |
NCBI chrNW_004936509:6,589,967...6,621,171
|
|
G |
Nfkbia |
NFKB inhibitor alpha |
treatment |
ISO |
|
RGD |
PMID:21122797 |
RGD:10413868 |
NCBI chrNW_004936494:9,537,793...9,541,187
|
|
G |
Ngf |
nerve growth factor |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:10408807 |
|
NCBI chrNW_004936627:635,784...641,290
|
|
G |
Ngfr |
nerve growth factor receptor |
treatment |
ISO |
|
RGD |
PMID:22678884 |
RGD:10413900 |
NCBI chrNW_004936490:12,038,500...12,057,257
|
|
G |
Nod2 |
nucleotide binding oligomerization domain containing 2 |
treatment |
ISO |
|
RGD |
PMID:24842554 |
RGD:13204729 |
NCBI chrNW_004936475:3,708,069...3,742,845
|
|
G |
Nos2 |
nitric oxide synthase 2 |
|
ISO |
mRNA:increased expression:brain (mouse) protein:increased expression:brain (rat) |
RGD |
PMID:21959178 PMID:22020035 |
RGD:5508751 RGD:5509037 |
NCBI chrNW_004936538:4,052,277...4,097,051
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
treatment |
ISO |
protein:increased expression:brain |
RGD |
PMID:21120604 PMID:25069640 |
RGD:11035212 RGD:5133239 |
NCBI chrNW_004936475:19,771,384...19,785,034
|
|
G |
Nrg1 |
neuregulin 1 |
treatment |
ISO |
|
RGD |
PMID:20691195 |
RGD:10449015 |
NCBI chrNW_004936766:1,104,841...1,306,368
|
|
G |
Ogg1 |
8-oxoguanine DNA glycosylase |
treatment |
ISO |
associated with Hypertension |
RGD |
PMID:17920569 |
RGD:8657395 |
NCBI chrNW_004936602:3,411,106...3,418,826
|
|
G |
Park7 |
Parkinsonism associated deglycase |
treatment |
ISO |
|
RGD |
PMID:17882163 |
RGD:13463450 |
NCBI chrNW_004936623:2,422,780...2,436,817
|
|
G |
Parp1 |
poly(ADP-ribose) polymerase 1 |
treatment |
ISO |
|
RGD |
PMID:21311064 PMID:23143152 PMID:23801245 PMID:25882840 |
RGD:10054501 RGD:11073732 RGD:13792686 RGD:5683909 |
NCBI chrNW_004936526:3,102,468...3,147,601
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
treatment |
ISO |
protein:increased expression:brain: |
RGD |
PMID:11323519 PMID:16403464 PMID:19352052 |
RGD:9835380 RGD:9835381 RGD:9850083 |
NCBI chrNW_004936698:650,225...746,593
|
|
G |
Pdgfra |
platelet derived growth factor receptor alpha |
treatment |
ISO |
|
RGD |
PMID:16917016 |
RGD:11084934 |
NCBI chrNW_004936482:16,804,129...16,853,539
|
|
G |
Pdgfrb |
platelet derived growth factor receptor beta |
treatment |
ISO |
|
RGD |
PMID:16917016 |
RGD:11084934 |
NCBI chrNW_004936504:4,762,251...4,799,789
|
|
G |
Plat |
plasminogen activator, tissue type |
|
ISO |
CTD Direct Evidence: therapeutic |
RGD CTD |
PMID:12297567 PMID:14512838 PMID:17690543 PMID:18453163 PMID:20547619 PMID:29651748 |
RGD:1580876 |
NCBI chrNW_004936785:476,200...503,371
|
|
G |
Plau |
plasminogen activator, urokinase |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:11677890 PMID:15181847 PMID:17702958 |
|
NCBI chrNW_004936521:5,238,128...5,243,829
|
|
G |
Pld1 |
phospholipase D1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12374626 |
|
NCBI chrNW_004936593:844,634...1,049,478
|
|
G |
Prkcg |
protein kinase C gamma |
|
ISO |
|
RGD |
PMID:14688616 |
RGD:1358416 |
NCBI chrNW_004936994:87,525...105,125
|
|
G |
Proc |
protein C, inactivator of coagulation factors Va and VIIIa |
treatment |
ISO |
|
RGD |
PMID:24159062 |
RGD:11100027 |
NCBI chrNW_004936469:43,841,989...43,850,322
|
|
G |
Ptprz1 |
protein tyrosine phosphatase receptor type Z1 |
|
ISO |
mRNA:increased expression:cerebral cortex |
RGD |
PMID:15869933 |
RGD:9590118 |
NCBI chrNW_004936605:3,195,893...3,368,102
|
|
G |
Reln |
reelin |
severity |
ISO |
|
RGD |
PMID:16438965 |
RGD:13207538 |
NCBI chrNW_004936479:19,628,488...20,088,278
|
|
G |
Rgma |
repulsive guidance molecule BMP co-receptor a |
treatment |
ISO |
|
RGD |
PMID:21840379 PMID:23275173 |
RGD:9850121 RGD:9850122 |
NCBI chrNW_004936483:9,753,112...9,792,817
|
|
G |
Rpl28 |
ribosomal protein L28 |
|
ISO |
|
RGD |
PMID:16805800 |
RGD:6480229 |
NCBI chrNW_004936886:633,303...635,888
|
|
G |
S100a5 |
S100 calcium binding protein A5 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:25257527 |
|
NCBI chrNW_004936580:3,349,655...3,353,601
|
|
G |
Serpine1 |
serpin family E member 1 |
|
ISO |
|
RGD |
PMID:14512838 |
RGD:1580876 |
NCBI chrNW_004936543:1,032,543...1,040,956
|
|
G |
Serpinf1 |
serpin family F member 1 |
treatment |
ISO |
|
RGD |
PMID:22714093 |
RGD:8655545 |
NCBI chrNW_004936538:7,885,816...7,898,308
|
|
G |
Serpinh1 |
serpin family H member 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12374626 |
|
NCBI chrNW_004936498:4,341,944...4,351,432
|
|
G |
Shh |
sonic hedgehog signaling molecule |
treatment |
ISO |
|
RGD |
PMID:22324418 |
RGD:12879461 |
NCBI chrNW_004936527:10,033,095...10,042,713
|
|
G |
Sirt1 |
sirtuin 1 |
treatment |
ISO |
|
RGD |
PMID:23600725 |
RGD:9585664 |
NCBI chrNW_004936521:10,296,097...10,316,673
|
|
G |
Slc12a2 |
solute carrier family 12 member 2 |
treatment |
ISO |
protein:increased expression:brain: |
RGD |
PMID:12535773 PMID:27798271 |
RGD:14398833 RGD:1580583 |
NCBI chrNW_004936504:1,378,812...1,465,463
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
treatment |
ISO |
|
RGD |
PMID:9419067 |
RGD:12879855 |
NCBI chrNW_004936474:24,205,878...24,236,611
|
|
G |
Slc9a1 |
solute carrier family 9 member A1 |
treatment |
ISO |
|
RGD |
PMID:31250553 |
RGD:14985213 |
NCBI chrNW_004936474:11,460,266...11,517,420
|
|
G |
Slpi |
secretory leukocyte peptidase inhibitor |
treatment |
ISO |
|
RGD |
PMID:14500739 |
RGD:9999390 |
NCBI chrNW_004936514:7,618,382...7,620,790
|
|
G |
Smo |
smoothened, frizzled class receptor |
treatment |
ISO |
|
RGD |
PMID:23499832 PMID:23696546 |
RGD:12832759 RGD:12879404 |
NCBI chrNW_004936579:5,893,064...5,917,021
|
|
G |
Smox |
spermine oxidase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:30576531 |
|
NCBI chrNW_004936485:14,566,570...14,603,323
|
|
G |
Snap91 |
synaptosome associated protein 91 |
|
ISO |
protein:increased degradation:brain |
RGD |
PMID:19240038 |
RGD:13461853 |
NCBI chrNW_004936510:7,222,200...7,345,138
|
|
G |
Sod1 |
superoxide dismutase 1 |
treatment |
ISO |
mRNA, protein:increased expression:cerebral cortex (rat) |
RGD |
PMID:22001340 PMID:22133807 |
RGD:8657021 RGD:8657023 |
NCBI chrNW_004936500:10,345,154...10,352,873
|
|
G |
Sod2 |
superoxide dismutase 2 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chrNW_004936489:11,178,338...11,191,601
|
|
G |
Sphk2 |
sphingosine kinase 2 |
|
ISO |
CTD Direct Evidence: therapeutic |
CTD |
PMID:23043544 |
|
NCBI chrNW_004936664:2,668,708...2,676,608
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:21940958 |
|
NCBI chrNW_004936490:17,119,189...17,178,402
|
|
G |
Tgfb1 |
transforming growth factor beta 1 |
|
ISO |
|
RGD |
PMID:31409163 |
RGD:14995477 |
NCBI chrNW_004936661:3,742,080...3,758,266
|
|
G |
Th |
tyrosine hydroxylase |
|
ISO |
protein:decreased expression:substantia nigra pars compacta, neuron (rat) |
RGD |
PMID:21366664 |
RGD:5128609 |
NCBI chrNW_004936794:478,651...486,887
|
|
G |
Tnf |
tumor necrosis factor |
treatment |
ISO |
|
RGD |
PMID:15647744 PMID:24916922 PMID:29498696 |
RGD:10450594 RGD:13792833 RGD:13825261 |
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Tnfaip6 |
TNF alpha induced protein 6 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12374626 |
|
NCBI chrNW_004936469:26,129,339...26,145,464
|
|
G |
Tnfrsf1a |
TNF receptor superfamily member 1A |
|
ISO |
|
RGD |
PMID:15647744 |
RGD:13825261 |
NCBI chrNW_004936709:1,407,327...1,421,448
|
|
G |
Upp1 |
uridine phosphorylase 1 |
|
ISO |
mRNA, protein:increased expression:brain (rat) |
RGD |
PMID:18457515 |
RGD:2317094 |
NCBI chrNW_004936478:22,508,602...22,531,604
|
|
G |
Xdh |
xanthine dehydrogenase |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:12374626 |
|
NCBI chrNW_004936493:1,762,814...1,824,501
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
|
ISO |
ClinVar Annotator: match by term: Moyamoya disease |
ClinVar |
PMID:25741868 PMID:28492532 |
|
NCBI chrNW_004936735:266,918...283,858
|
|
G |
Fas |
Fas cell surface death receptor |
|
ISO |
ClinVar Annotator: match by term: Moyamoya disease |
ClinVar |
|
|
NCBI chrNW_004936735:209,369...234,582
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
ISO |
|
RGD |
PMID:16723886 |
RGD:1580650 |
NCBI chrNW_004936594:3,232,433...3,244,241
|
|
|
G |
Gucy1a1 |
guanylate cyclase 1 soluble subunit alpha 1 |
|
ISO |
ClinVar Annotator: match by term: Moyamoya disease 1 |
ClinVar |
PMID:26777256 |
|
NCBI chrNW_004936576:2,353,874...2,411,747
|
|
|
G |
Rnf213 |
ring finger protein 213 |
susceptibility |
ISO |
ClinVar Annotator: match by term: Moyamoya disease 2 CTD Direct Evidence: marker/mechanism |
OMIM ClinVar CTD |
PMID:21048783 PMID:21799892 PMID:22377813 PMID:22931863 PMID:25278557 PMID:25741868 PMID:28492532 PMID:31474762 |
|
NCBI chrNW_004936594:4,241,006...4,331,841
|
|
|
G |
Bcap31 |
B cell receptor associated protein 31 |
|
ISO |
ClinVar Annotator: match by term: Chromosome Xq28 deletion syndrome |
ClinVar |
PMID:24011989 PMID:25741868 |
|
NCBI chrNW_004936809:582,689...614,800
|
|
G |
Slc6a8 |
solute carrier family 6 member 8 |
|
ISO |
ClinVar Annotator: match by term: Chromosome Xq28 deletion syndrome |
ClinVar |
PMID:24011989 |
|
NCBI chrNW_004936809:571,234...578,298
|
|
|
G |
Acta2 |
actin alpha 2, smooth muscle |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936735:266,918...283,858
|
|
|
G |
Gucy1a1 |
guanylate cyclase 1 soluble subunit alpha 1 |
|
ISO |
|
OMIM |
|
|
NCBI chrNW_004936576:2,353,874...2,411,747
|
|
|
G |
App |
amyloid beta precursor protein |
|
ISO |
protein:decreased expression:cerebrospinal fluid: |
RGD |
PMID:1677459 |
RGD:10054257 |
NCBI chrNW_004936640:1,549,977...1,787,436
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:18938189 |
RGD:10054050 |
NCBI chrNW_004936664:2,968,103...2,973,652
|
|
G |
Bcl2 |
BCL2 apoptosis regulator |
treatment |
ISO |
|
RGD |
PMID:18938189 |
RGD:10054050 |
NCBI chrNW_004936497:2,209,136...2,373,580
|
|
G |
G6pd |
glucose-6-phosphate dehydrogenase |
treatment |
ISO |
|
RGD |
PMID:21279683 |
RGD:10449132 |
NCBI chrNW_004936809:1,269,900...1,285,853
|
|
G |
Il2 |
interleukin 2 |
severity |
ISO |
protein:increased secretion:mononuclear cell: |
RGD |
PMID:8586980 |
RGD:10047081 |
NCBI chrNW_004936662:1,594,953...1,599,625
|
|
|
G |
App |
amyloid beta precursor protein |
|
ISO |
ClinVar Annotator: match by term: Vascular dementia |
ClinVar |
PMID:22312439 PMID:25104557 PMID:25174650 PMID:25604855 PMID:26242991 PMID:26467025 PMID:27312774 PMID:28492532 |
|
NCBI chrNW_004936640:1,549,977...1,787,436
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
|
ISO |
|
RGD |
PMID:24448401 |
RGD:14696801 |
NCBI chrNW_004936517:743,036...752,836
|
|
G |
Bdnf |
brain derived neurotrophic factor |
treatment |
ISO |
|
RGD |
PMID:24622829 |
RGD:10059369 |
NCBI chrNW_004936540:5,530,081...5,582,765
|
|
G |
C1r |
complement C1r |
|
ISO |
ClinVar Annotator: match by term: Vascular dementia |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936709:709,001...719,758
|
|
G |
Cacna1a |
calcium voltage-gated channel subunit alpha1 A |
|
ISO |
ClinVar Annotator: match by term: Vascular dementia |
ClinVar |
PMID:25741868 |
|
NCBI chrNW_004936659:2,201,606...2,269,625
|
|
G |
Ccm2 |
CCM2 scaffold protein |
|
ISO |
ClinVar Annotator: match by term: Vascular dementia |
ClinVar |
|
|
NCBI chrNW_004936478:19,820,092...19,882,358
|
|
G |
Cdk5 |
cyclin dependent kinase 5 |
treatment |
ISO |
|
RGD |
PMID:27118553 |
RGD:13792766 |
NCBI chrNW_004936527:6,478,934...6,483,848
|
|
G |
Col4a1 |
collagen type IV alpha 1 chain |
|
ISO |
ClinVar Annotator: match by term: Vascular dementia |
ClinVar |
|
|
NCBI chrNW_004936472:2,416,043...2,543,561
|
|
G |
Col4a2 |
collagen type IV alpha 2 chain |
|
ISO |
ClinVar Annotator: match by term: Vascular dementia |
ClinVar |
|
|
NCBI chrNW_004936472:2,270,836...2,416,324
|
|
G |
Eif4e |
eukaryotic translation initiation factor 4E |
|
ISO |
protein:decreased expression:hippocampus |
RGD |
PMID:23053837 |
RGD:10401142 |
NCBI chrNW_004936520:3,922,457...3,964,721
|
|
G |
Epo |
erythropoietin |
|
ISO |
|
RGD |
PMID:17037738 |
RGD:10400891 |
NCBI chrNW_004936543:742,722...745,332
|
|
G |
Fgfr1 |
fibroblast growth factor receptor 1 |
treatment |
ISO |
|
RGD |
PMID:22500404 |
RGD:10402076 |
NCBI chrNW_004936710:1,760,365...1,815,269
|
|
G |
Flt1 |
fms related receptor tyrosine kinase 1 |
treatment |
ISO |
|
RGD |
PMID:22500404 |
RGD:10402076 |
NCBI chrNW_004936472:23,442,946...23,617,523
|
|
G |
Gclm |
glutamate-cysteine ligase modifier subunit |
susceptibility |
ISO |
associated with stroke;DNA:polymorphism:promoter:-588C>T(human) |
RGD |
PMID:17548779 |
RGD:10402374 |
NCBI chrNW_004936537:5,356,914...5,378,998
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
treatment |
ISO |
|
RGD |
PMID:24968700 |
RGD:11352822 |
NCBI chrNW_004936529:997,943...999,123
|
|
G |
Grin1 |
glutamate ionotropic receptor NMDA type subunit 1 |
|
ISO |
associated with Alzheimer's disease |
RGD |
PMID:25261450 |
RGD:13792687 |
NCBI chrNW_004936669:814,330...838,881
|
|
G |
Grin2a |
glutamate ionotropic receptor NMDA type subunit 2A |
|
ISO |
|
RGD |
PMID:25261450 |
RGD:13792687 |
NCBI chrNW_004936530:8,286,101...8,612,183
|
|
G |
Grin2b |
glutamate ionotropic receptor NMDA type subunit 2B |
severity |
ISO |
|
RGD |
PMID:25261450 |
RGD:13792687 |
NCBI chrNW_004936587:3,406,055...3,806,956
|
|
G |
Gsk3b |
glycogen synthase kinase 3 beta |
treatment |
ISO |
|
RGD |
PMID:27118553 |
RGD:13792766 |
NCBI chrNW_004936536:6,730,070...6,893,818
|
|
G |
Hspa1a |
heat shock protein family A (Hsp70) member 1A |
|
ISO |
DNA:polymorphism: :-110A>C(human) |
RGD |
PMID:15832029 |
RGD:10402403 |
NCBI chrNW_004936727:1,732,323...1,735,128
|
|
G |
Htra1 |
HtrA serine peptidase 1 |
|
ISO |
ClinVar Annotator: match by term: Vascular dementia |
ClinVar |
PMID:24500651 |
|
NCBI chrNW_004936486:11,271,130...11,317,271
|
|
G |
Igf1 |
insulin like growth factor 1 |
severity |
ISO |
mRNA,protein:decreased expression:hippocampus: |
RGD |
PMID:16181175 PMID:22342912 |
RGD:10045864 RGD:1598446 |
NCBI chrNW_004936492:11,709,623...11,784,028
|
|
G |
Igf1r |
insulin like growth factor 1 receptor |
|
ISO |
|
RGD |
PMID:16983186 |
RGD:10045873 |
NCBI chrNW_004936483:4,563,995...4,860,231
|
|
G |
Il1b |
interleukin 1 beta |
|
ISO |
protein:increased expression:plasma |
RGD |
PMID:16600299 |
RGD:1626633 |
NCBI chrNW_004936783:1,251,678...1,256,807
|
|
G |
Itm2b |
integral membrane protein 2B |
|
ISO |
ClinVar Annotator: match by term: Vascular dementia |
ClinVar |
|
|
NCBI chrNW_004936565:1,535,570...1,557,667
|
|
G |
Krit1 |
KRIT1 ankyrin repeat containing |
|
ISO |
ClinVar Annotator: match by term: Vascular dementia |
ClinVar |
|
|
NCBI chrNW_004936621:2,088,606...2,128,579
|
|
G |
Mapt |
microtubule associated protein tau |
treatment |
ISO |
|
RGD |
PMID:27118553 |
RGD:13792766 |
NCBI chrNW_004936541:2,381,411...2,479,984
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
|
ISO |
|
RGD |
PMID:16385583 |
RGD:1582624 |
NCBI chrNW_004936475:7,801,356...7,825,831
|
|
G |
Mtor |
mechanistic target of rapamycin kinase |
|
ISO |
protein:decreased expression:hippocampus |
RGD |
PMID:23053837 |
RGD:10401142 |
NCBI chrNW_004936474:158,376...282,310
|
|
G |
Notch3 |
notch receptor 3 |
|
ISO |
ClinVar Annotator: match by term: Vascular dementia |
ClinVar |
PMID:26308724 PMID:26467025 PMID:27844030 |
|
NCBI chrNW_004936596:5,265,984...5,301,430
|
|
G |
Nppa |
natriuretic peptide A |
|
ISO |
ClinVar Annotator: match by term: Vascular dementia |
ClinVar |
|
|
NCBI chrNW_004936474:671,362...673,610
|
|
G |
Pon2 |
paraoxonase 2 |
|
ISO |
DNA:missense mutation:cds:p.C311S (human) |
RGD |
PMID:11803456 |
RGD:1580219 |
NCBI chrNW_004936585:4,862,378...4,894,061
|
|
G |
Psen2 |
presenilin 2 |
|
ISO |
ClinVar Annotator: match by term: Vascular dementia |
ClinVar |
|
|
NCBI chrNW_004936526:3,584,194...3,611,719
|
|
G |
Rpgrip1l |
RPGRIP1 like |
susceptibility |
ISO |
DNA:SNPs:introns:rs16952362,rs17214955,rs17803830(human) |
RGD |
PMID:22425971 |
RGD:13204815 |
NCBI chrNW_004936475:6,219,187...6,321,612
|
|
G |
Rps6 |
ribosomal protein S6 |
treatment |
ISO |
|
RGD |
PMID:25767501 |
RGD:11041644 |
NCBI chrNW_004936652:1,252,986...1,255,987
|
|
G |
Sdhaf1 |
succinate dehydrogenase complex assembly factor 1 |
|
ISO |
CTD Direct Evidence: marker/mechanism |
CTD |
PMID:19465911 |
|
NCBI chrNW_004936922:32,655...33,795
|
|
G |
Snca |
synuclein alpha |
|
ISO |
protein:increased expression:cerebrospinal fluid |
RGD |
PMID:18577885 |
RGD:6478792 |
NCBI chrNW_004936685:2,077,017...2,175,298
|
|
G |
Sncg |
synuclein gamma |
|
ISO |
protein:increased expression:cerebrospinal fluid |
RGD |
PMID:18577885 |
RGD:6478792 |
NCBI chrNW_004936804:16,869...21,684
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
|
ISO |
DNA:SNPs, haplotype: :24489C>T, 34995G>T, 68891C>T (human) |
RGD |
PMID:16082694 |
RGD:1581412 |
NCBI chrNW_004936492:115,923...174,614
|
|
G |
Sst |
somatostatin |
|
ISO |
protein:decreased expression:brain |
RGD |
PMID:18925713 |
RGD:2303174 |
NCBI chrNW_004936578:2,464,310...2,465,673
|
|
G |
Tmem106b |
transmembrane protein 106B |
|
ISO |
ClinVar Annotator: match by term: Vascular dementia |
ClinVar |
|
|
NCBI chrNW_004936761:1,663,099...1,689,580
|
|
G |
Tnf |
tumor necrosis factor |
susceptibility |
ISO |
DNA:polymorphism:promoter:-850C>T(human) |
RGD |
PMID:11273064 |
RGD:13825254 |
NCBI chrNW_004936727:1,936,066...1,937,766
|
|
G |
Tp53 |
tumor protein p53 |
|
ISO |
protein:increased expression:brain |
RGD |
PMID:18083315 |
RGD:2290557 |
NCBI chrNW_004936595:919,807...935,367
|
|